✦ LIBER ✦

Adjuvant Trastuzumab Therapy In Her2-Positive Breast Cancer Patients: A Meta-Analysis Of Published Randomized Trials

✍ Scribed by Xia, Y.; Bian, B.; Costea, E.; Kelton, C.M.; Guo, J.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab in elderly with HER

✍ Janaina Brollo; Giuseppe Curigliano; Davide Disalvatore; Bianca Fontana Marrone; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

A Meta-Analysis of Randomized Controlled

✍ Cun Liao; Fang Yin; Ping Huang; Yunfei Cao; Feng Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

An Economic Evaluation of Adjuvant Trast

✍ Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Prognostic value of phosphorylated HER2

✍ Kurebayashi, Junichi; Kanomata, Naoki; Yamashita, Tetsumasa; Shimo, Toshiro; Miz 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 412 KB

PCN28 COST-UTILITY ANALYSIS IN A SPANISH

✍ C Polanco; M Carulla; X Badia; A Ramirez-Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

2-year follow-up of trastuzumab after ad

✍ Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyerei 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB